Volume 11, Number 3—March 2005
SARS-associated Coronavirus Transmitted from Human to Pig
Highlight and copy the desired format.
|EID||Chen W, Yan M, Yang L, Ding B, He B, Wang Y, et al. SARS-associated Coronavirus Transmitted from Human to Pig. Emerg Infect Dis. 2005;11(3):446-448. https://dx.doi.org/10.3201/eid1103.040824|
|AMA||Chen W, Yan M, Yang L, et al. SARS-associated Coronavirus Transmitted from Human to Pig. Emerging Infectious Diseases. 2005;11(3):446-448. doi:10.3201/eid1103.040824.|
|APA||Chen, W., Yan, M., Yang, L., Ding, B., He, B., Wang, Y....Wang, J. (2005). SARS-associated Coronavirus Transmitted from Human to Pig. Emerging Infectious Diseases, 11(3), 446-448. https://dx.doi.org/10.3201/eid1103.040824.|
coronavirus (SARS-CoV) was isolated from a pig during a survey for possible routes of viral transmission after a SARS epidemic. Sequence and epidemiology analyses suggested that the pig was infected by a SARS-CoV of human origin.
Severe acute respiratory syndrome (SARS) was first identified in Guangdong Province, China, in November 2002 (1). A novel coronavirus, SARS-CoV, was identified as the pathogen; several possible origins of the coronavirus were suggested from wild animal reservoirs, such as Himalayan palm civets and raccoon dogs (2–8). The virus infects many other wild and domesticated animals, such as Mustela furo, Felis domesticus, and Nyctereutes procyonoides (9,10), but infection of domesticated pigs has not been previously reported.
We surveyed 6 major domestic animal species that are in close contact with humans and could be infected by SARS-CoV if transmission were possible. The survey was conducted in a suburban area and its extended farming villages, Xiqing County of Tianjin, China, where a SARS outbreak occurred in late spring of 2003. Animal samples, blood and fecal swab specimens, for antibody and RNA detection were collected from the sites and transported on ice to a biosafety level 3 laboratory within 24 hours. We used 2 types of assays for the initial viral screen, immunologic assays to identify antibodies and reverse transcription–polymerase chain reaction (RT-PCR) to detect the viral genome. The immunoassays were carried out by the double-antigen sandwich method with a recombinant N protein and a partial S protein of SARS-CoV, and results were confirmed by Western blot (11). RT-PCR with virus-specific primers was used to detect viral genome RNA, which was extracted from blood samples with a QIAamp RNA Blood Mini Kit (Qiagen, Hilden, Germany) and from fecal swabs with Trizol Reagent (Invitrogen, Carlsbad, CA, USA).. Total RNA was then reverse transcribed with random hexamers, and cDNA was amplified with a nested PCR method (12). We also isolated viruses from Vero E6 cultures, performed a cross-neutralization test, and sequenced the viral genome (13).
Of 242 animals surveyed, we identified 2 antibody-positive samples from 2 pigs; test results for the other 240 animals were negative (Table 1 and Figure 1). Of 93 blood specimens and 15 fecal swabs on which we performed RT-PCR, 1 of the same 2 pigs tested positive. We subsequently obtained 2 viral isolates from its blood and fecal samples, designated TJB and TJF, respectively. We also performed follow-up studies for 4 weeks on the infected pig until its blood tested negative with our RT-PCR assay. The animal later died giving birth. We also tested serum samples from the swineherd on the farm and a few persons who may have had contact with the swineherd. All were negative by the tests that we conducted.
Using a viral isolate, TJF, we conducted cross-neutralization experiments with antisera and an early viral isolate, BJ01 (8), to prove their equivalent virulence (Table 2). We then sequenced TJF completely (GenBank accession no. AY654624) and compared its sequence to that of BJ01. Eighteen nucleotide (nt) substitutions are between the TJF and BJ01 sequences, and 4 of them are nonsynonymous over the entire length (29,708 bp). Two pieces of evidence strongly suggested a human origin for the TJF strain. First, it is only distantly related to SZ16, which was isolated from Himalayan palm civets of southern China, in which 64 substitutions over a length of 29,731 bp were found, 3.6 times more than were identified between TJF and BJ01. Second, a sequence signature (a 29-nt insertion [246 nt upstream of the N gene, from residues 27869 to 27897]) found only in an early isolate, GD01 (from Guangdong Province), but absent from all the SARS-CoV isolates so far discovered, is also absent in the TJF sequence (14). This sequence has been found in all coronavirus isolates of animal origin except from the pig identified in this study. Therefore, direct viral transmission of SARS-CoV from a human host to the pig bearing TJF is most likely. To further elucidate our point, we constructed a phylogenetic tree based on S-gene sequences; it shows that TJF is more closely related to human SARS-CoV isolates than to animal coronaviruses (Figure 2).
We have shown that human SARS-CoV can infect domesticated mammals, in particular, the pig. The direct source of SARS-CoV transmission to the identified infected pigs was most likely virus-contaminated animal feed because the farm where the infected pig was identified is rather remote, >1 km from the nearest village. The only person routinely in close contact with the animals is the swineherd, whose serum samples were negative for SARS-CoV on all tests. Swineherds in rural areas often obtain leftovers from restaurants in the cities for use as hogwash (without thoroughly fermenting it). Thus, even if no direct evidence for human-to-swine SARS-CoV transmission exists, a strong warning should be issued to prevent such a practice, or regulatory procedures should be instituted to block this route of disease propagation (15). Whether or not other domesticated (such as dogs and cats) and wild animals that are common in and around human settlements can easily contract and pass on SARS-CoV remains to be seen in future studies. Intensive surveillance and investigations on animals, especially during and after an outbreak of SARS, will lead to a better understanding and ability to control this disease’s natural animal reservoirs and to prevent interspecies transmission events.
Mr. Chen is a PhD candidate who works at the Beijing Genomics Institute, Chinese Academy of Sciences, Beijing, China. His primary research interests are molecular virology and infectious disease genomics.
This study was supported by grants from Chinese Academy of Sciences and Tianjin Institute of Animal Husbandry and Veterinary Science.
- World Health Organization. Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec. 2003;78:86.
- World Health Organization. Cumulative number of reported cases of severe acute respiratory syndrome (SARS) [monograph on the Internet]. 2003. [cited 4 Jul 2003]. Available from http: //www. who.int/csr/sars /country/ 2003_07_04/en/
- Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–25.
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–66.
- Drosten C, Günther S, Preiser W, Werf S, Brodt HR, Becker S, Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–76.
- Rota PA, Oberste MS, Monroe SS, Nix WA, Campganoli R, Icenogle JP, Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–9.
- Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–404.
- Qin E, Zhu Q, Yu M, Fan BC, Chang GH, Si BY, A complete sequence and comparative analysis of a SARS-associated virus (isolate BJ01). Chin Sci Bull. 2003;48:941–8.
- Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–8.
- Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Amerongen G, SARS virus infection of cats and ferrets. Nature. 2003;425:915.
- Towbin H, Stachelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350–4.
- Chen WJ, Xu ZY, Mu JS, Yang L, Gan HX, Mu F, Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. J Med Microbiol. 2004;53:435–8.
- Peng WM, Chang GH, Liu H, Yu M, Tang G, Fan BC, Cross neutralization reaction of SARS virus BJ01 and GZ01 strains with sera of SARS patients from Beijing and Guangzhou regions. Chin J Microbiol Immunol. 2003;23:495–7.
- Qin E, He XL, Tian W, Liu Y, Li W, Wen J, A genome sequence of novel SARS-CoV isolates: the genotype, GD-Ins29, leads to a hypothesis of viral transmission in South China. Genomics Proteomics Bioinformatics. 2003;1:101–7.
- World Health Organization. Sampling for severe acute respiratory syndrome (SARS) diagnostic tests [monograph on the Internet]. [cited 29 Apr 2003]. Available from http://www.who.int/csr/sars/sampling/en/
- Figure 1. . . Detection of antibodies against severe acute respiratory syndrome (SARS)–associated coronavirus recombinant proteins in animal sera by Western blotting. Recombinant nuleocapsid protein in panel A (NP, 54 kilodaltons...
- Figure 2. . . Phylogenetic analysis of severe acute respiratory syndrome–associated coronavirus S-gene. Nucleotide sequences of S genes (from 21491 to 25258 and 3768 bp in length) were compared. The result...
- Table 1. Animal surveys for antibodies to SARS-CoV and viral RNA
- Table 2. Cross-neutralization tests for severe acute respiratory syndrome (SARS)–associated coronavirus
Please use the form below to submit correspondence to the authors or contact them at the following address:
Jian Wang, Beijing Genomics Institute, Chinese Academy of Sciences, Beijing Airport Industry Zone B-6, Beijing, China 101300; fax: 8610-80485451
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: April 25, 2012
- Page last updated: April 25, 2012
- Page last reviewed: April 25, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)